ACADIA Pharmaceuticals Statistics
Total Valuation
ACAD has a market cap or net worth of $5.08 billion. The enterprise value is $4.20 billion.
| Market Cap | 5.08B |
| Enterprise Value | 4.20B |
Important Dates
The last earnings date was Tuesday, August 4, 2026, after market close.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ACAD has 172.31 million shares outstanding. The number of shares has increased by 2.98% in one year.
| Current Share Class | 172.31M |
| Shares Outstanding | 172.31M |
| Shares Change (YoY) | +2.98% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 0.55% |
| Owned by Institutions (%) | 73.17% |
| Float | 128.35M |
Valuation Ratios
The trailing PE ratio is 13.37 and the forward PE ratio is 37.19.
| PE Ratio | 13.37 |
| Forward PE | 37.19 |
| PS Ratio | 4.46 |
| Forward PS | 3.59 |
| PB Ratio | 3.89 |
| P/TBV Ratio | 4.22 |
| P/FCF Ratio | 34.90 |
| P/OCF Ratio | 31.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 42.69, with an EV/FCF ratio of 28.84.
| EV / Earnings | 11.04 |
| EV / Sales | 3.69 |
| EV / EBITDA | 42.69 |
| EV / EBIT | 48.63 |
| EV / FCF | 28.84 |
Financial Position
The company has a current ratio of 3.39, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.39 |
| Quick Ratio | 3.11 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.66 |
| Debt / FCF | 0.51 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 35.74% and return on invested capital (ROIC) is 19.82%.
| Return on Equity (ROE) | 35.74% |
| Return on Assets (ROA) | 3.64% |
| Return on Invested Capital (ROIC) | 19.82% |
| Return on Capital Employed (ROCE) | 6.25% |
| Weighted Average Cost of Capital (WACC) | 8.77% |
| Revenue Per Employee | $1.43M |
| Profits Per Employee | $476,797 |
| Employee Count | 798 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 14.77 |
Taxes
| Income Tax | -259.12M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.28% in the last 52 weeks. The beta is 0.85, so ACAD's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +18.28% |
| 50-Day Moving Average | 25.86 |
| 200-Day Moving Average | 24.16 |
| Relative Strength Index (RSI) | 62.65 |
| Average Volume (20 Days) | 1,801,266 |
Short Selling Information
The latest short interest is 10.81 million, so 6.27% of the outstanding shares have been sold short.
| Short Interest | 10.81M |
| Short Previous Month | 11.03M |
| Short % of Shares Out | 6.27% |
| Short % of Float | 8.42% |
| Short Ratio (days to cover) | 7.53 |
Income Statement
In the last 12 months, ACAD had revenue of $1.14 billion and earned $380.48 million in profits. Earnings per share was $2.21.
| Revenue | 1.14B |
| Gross Profit | 706.66M |
| Operating Income | 86.37M |
| Pretax Income | 121.37M |
| Net Income | 380.48M |
| EBITDA | 98.39M |
| EBIT | 86.37M |
| Earnings Per Share (EPS) | $2.21 |
Balance Sheet
The company has $956.47 million in cash and $73.85 million in debt, with a net cash position of $882.62 million or $5.12 per share.
| Cash & Cash Equivalents | 956.47M |
| Total Debt | 73.85M |
| Net Cash | 882.62M |
| Net Cash Per Share | $5.12 |
| Equity (Book Value) | 1.31B |
| Book Value Per Share | 7.59 |
| Working Capital | 863.11M |
Cash Flow
In the last 12 months, operating cash flow was $160.32 million and capital expenditures -$14.69 million, giving a free cash flow of $145.63 million.
| Operating Cash Flow | 160.32M |
| Capital Expenditures | -14.69M |
| Depreciation & Amortization | 12.02M |
| Net Borrowing | n/a |
| Free Cash Flow | 145.63M |
| FCF Per Share | $0.85 |
Margins
Gross margin is 62.06%, with operating and profit margins of 7.59% and 33.42%.
| Gross Margin | 62.06% |
| Operating Margin | 7.59% |
| Pretax Margin | 10.66% |
| Profit Margin | 33.42% |
| EBITDA Margin | 8.64% |
| EBIT Margin | 7.59% |
| FCF Margin | 12.79% |
Dividends & Yields
ACAD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.98% |
| Shareholder Yield | -2.98% |
| Earnings Yield | 7.49% |
| FCF Yield | 2.86% |
Analyst Forecast
The average price target for ACAD is $33.85, which is 14.75% higher than the current price. The consensus rating is "Buy".
| Price Target | $33.85 |
| Price Target Difference | 14.75% |
| Analyst Consensus | Buy |
| Analyst Count | 21 |
| Revenue Growth Forecast (3Y) | 14.45% |
| EPS Growth Forecast (3Y) | 26.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ACAD has an Altman Z-Score of 5.43 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.43 |
| Piotroski F-Score | 5 |